NIH's Role In Sustaining the U.S. Economy 2021 Update Now Available here
UMR Urges House and Senate Leaders to Include NIH Funding in COVID Relief Package read here
UMR releases new fact sheets on COVID-19 and biomedical research. Read here
See how UMR members are aiding in the fight against the coronavirus here
A new episode of the Amazing Things Podcast is now available! Check it out here.

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Johns Hopkins Study Finds Patients Hospitalized with Omicron Face Similar Risks to Those with Delta

Johns Hopkins Study Finds Patients Hospitalized with Omicron Face Similar Risks to Those with Delta

Patients hospitalized with the omicron or delta variants of COVID-19 required similar levels of respiratory support and intensive care, according to a new Johns Hopkins study, indicating that omicron infections should not be underestimated.  

Inflammation, Rather Than Virus Provoking It, May Be Key to COVID-19 Loss of Smell

While the devastating impacts of COVID-mediated anosmia are well known, the biological mechanisms underlying the condition remain somewhat of a mystery. In a study published today in JAMA Neurology, a Johns Hopkins Medicine-led team shows that loss of smell is most likely a secondary consequence of inflammation occurring when the body’s immune system responds to … Continued

Johns Hopkins-Led Study Finds Convalescent Plasma Can Be Effective Early COVID-19 Therapy

The New England Journal of Medicine (NEJM) today published final results of a nationwide multicenter study led by researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health that show plasma from patients who have recovered from COVID-19 and whose blood contains antibodies against SARS-CoV-2, the causative virus, is an effective … Continued

Mutations Leading to Omicron Variant Did Not Enable Virus to Fully Escape Immune System

People who gained immunity — either through vaccination or exposure — against the original strain of SARS-CoV-2, the virus that causes COVID-19, also are likely to have some protection against the pathogen’s omicron variant. That’s because the mutations that led to the variant’s emergence aren’t found in the regions of the virus that stimulates one … Continued

Current mRNA vaccines may elicit immune responses to other bat coronaviruses, study finds

Surveillance studies have shown that bats are reservoirs for SARS-related and other diverse coronaviruses, including SARS-CoV-2, the virus that causes COVID-19 that is believed to have originated in bats. Such zoonotic diseases pose a significant threat to humans. But a future vaccine providing protection against a wide range of coronaviruses may be possible, say Johns … Continued

Metabolism of COVID-19 Antibodies from Convalescent Plasma Suggests Possible Safe Treatment for High Risk Children

Johns Hopkins Medicine researchers report that a prospective study of 14 infants and children demonstrated that convalescent plasma — a blood product collected from patients recovered from infections with the coronavirus (SARS-CoV-2) that causes COVID-19— was safe in high risk children infected with or exposed to the virus. The study, published Jan. 25 in the … Continued

Study: Rapid Test for Detecting COVID-19 Highly Accurate for Children and Adolescents

In a large prospective study of just over 1,000 patients ages 17 and younger who were seen at the Baltimore Convention Center Field Hospital (BCCFH) testing site during a seven-month period last year, researchers from Johns Hopkins Medicine and collaborating institutions report that a rapid antigen test for SARS-CoV-2 — the virus that causes COVID-19 … Continued

Early Use of Convalescent Plasma May Help Outpatients with COVID-19 Avoid Hospitalization

The results of a nationwide, multicenter clinical trial led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health provides solid evidence for the use of plasma from convalescent patients — those who have recovered from the disease and whose blood contains antibodies against SARS-CoV-2, the virus that causes COVID-19 — as … Continued

Johns Hopkins Children’s Center Awarded Grant to Study COVID-19 Safety Measures in Schools

Experts with the Rales Center for the Integration of Health and Education at Johns Hopkins Children’s Center, the Johns Hopkins Consortium for School-Based Health Solutions and the Johns Hopkins Center for Communication Programs have been awarded a one-year, $1.47 million grant from the National Institutes of Health (NIH) to embark on the Parents and Communities … Continued

“Public Health on Call” Podcast: Checking In With A COVID Long-hauler